AstraZeneca
AZN
$72.59
Share price
-0.34%
Change (1 day)
14.28%
Change (1 year)
Categories
EPS for AstraZeneca (AZN)
EPS in 2023 (TTM): $1.52
According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $1.52. In 2022 the company made an earnings per share (EPS) of $1.06 an increase over its 2021 EPS that were of $0.14.
EPS history for AstraZeneca from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.52 | 42.92% |
| 2022 | $1.06 | 631.03% |
| 2021 | $0.14 | -88.11% |
| 2020 | $1.22 | 136.89% |
| 2019 | $0.51 | -39.41% |
| 2018 | $0.85 | -28.27% |
| 2017 | $1.18 | -14.37% |
| 2016 | $1.38 | 24.11% |
| 2015 | $1.12 | 127.55% |
| 2014 | $0.49 | -51.96% |
| 2013 | $1.02 | -58.95% |
| 2012 | $2.48 | -32.2% |
| 2011 | $3.66 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $4.84 | 219.56% | 🇺🇸 USA |
 Novartis NVS | $3.28 | 116.50% | 🇨🇭 Switzerland |
 Pfizer PFE | $5.18 | 241.91% | 🇺🇸 USA |
 Abbott Laboratories ABT | $3.66 | 141.26% | 🇺🇸 USA |
 Eli Lilly LLY | $6.82 | 350.12% | 🇺🇸 USA |
 Sanofi SNY | $2.85 | 87.80% | 🇫🇷 France |
 Biogen BIIB | $21.62 | 1,327.06% | 🇺🇸 USA |
 Merck MRK | $5.73 | 278.22% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.46 | 128.38% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $8.03 | 430.18% | 🇬🇧 UK |